跳至主要内容
临床试验/NCT00994032
NCT00994032已完成不适用

Analysis of the Impact in the Quality of Life of Patients With Pain Secondary to Osteoporotic Vertebral Fractures Receiving Conservative Treatment Versus Percutaneous Vertebroplasty

Hospital Clinic of Barcelona2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2006年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
2
主要终点
Impact into quality of life with the Qualeffo-41 test

研究概览

简要总结

The purpose of this study is to determine whether percutaneous vertebroplasty is able to improve long-term quality of life in patients with pain secondary to osteoporotic vertebral fractures, compared to conventional medical treatment.

详细描述

Osteoporotic vertebral fractures are associated with pain and severe disability in a high percentage of patients. Vertebroplasty has become the treatment of choice to alleviate pain in those patients who have not responded to medical treatment.Although several case series and non-randomized studies have shown the effectiveness of vertebroplasty in alleviating pain secondary to osteoporotic vertebral fractures, the long-term effect of this treatment has not been compared to standard medical treatment in a randomized study.

In our study we have analyzed the long-term effect of vertebroplasty in terms of quality of life in patients with painful osteoporotic vertebral fractures, randomizing them into two arms: percutaneous vertebroplasty or conventional medical treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Painful (pain intensity of at least 4 on a scale from 0 to 10) osteoporotic vertebral fracture between levels T4 and L5
  • Fragility; i.e. fracture not in relation with significant trauma
  • Recent fracture, pain beginning not earlier than 1 year before inclusion

排除标准

  • No vertebral edema on STIR MR images
  • Uncorrectable bleeding diatheses
  • Active infection
  • Substantial retropulsion of bony fragments
  • Non-osteoporotic fracture
  • Concomitant neoplasm

结局指标

主要结局

Impact into quality of life with the Qualeffo-41 test

时间窗: Baseline, 2 weeks, 2 months, 6 months and 1 year

次要结局

  • Analyze pain alleviation with the Analog Visual Scale(Baseline, 2 weeks, 2 months, 6 months and 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

JORDI BLASCO ANDALUZ

MD, PhD

Hospital Clinic of Barcelona

研究点 (2)

Loading locations...

相似试验